Medicaid coverage for weight loss medications varies dramatically by state, and the landscape is shifting fast. As of early 2026, only 13 state Medicaid programs cover GLP-1 injectable medications (like Wegovy) specifically for obesity treatment. Older, less expensive oral medications are more widely available, but even those require prior authorization in most states.
Why Coverage Depends on Your State
Unlike many other drug categories, federal law does not require state Medicaid programs to cover medications prescribed solely for weight loss. States can choose to include them or not. This means a medication that’s fully covered in one state may be completely unavailable through Medicaid across the border.
The situation has actually gotten more restrictive recently. California, New Hampshire, Pennsylvania, and South Carolina all eliminated Medicaid coverage of GLP-1 medications for obesity treatment after October 2025, largely due to cost concerns. North Carolina reinstated coverage in December 2025, but only after initially cutting it. These shifts happen with relatively little notice, making it difficult for patients to plan long-term treatment.
GLP-1 Injectables: Limited Access
The newer GLP-1 injectable medications, including semaglutide (Wegovy) and tirzepatide (Zepbound), are the most effective weight loss drugs currently available, producing average weight loss of 15% or more of body weight in clinical trials. They’re also the hardest to get through Medicaid. Only 13 state Medicaid programs cover these drugs for obesity under fee-for-service as of January 2026.
Even in states that do cover GLP-1s for weight loss, the approval criteria tend to be far stricter than for private insurance. One state Medicaid plan’s criteria illustrate a common pattern: GLP-1 medications are classified as “non-preferred” agents and require the patient to be classified as morbidly obese, meaning a BMI of 40 or higher. That’s a significantly higher bar than the FDA label, which approves these drugs for anyone with a BMI of 30 or above (or 27 with a weight-related health condition).
It’s worth noting that these same GLP-1 medications are often covered by Medicaid when prescribed for type 2 diabetes rather than weight loss. If you have diabetes and your doctor prescribes semaglutide (marketed as Ozempic for diabetes), coverage is generally much easier to obtain because it falls under standard drug benefit rules rather than the optional weight loss category.
Older Oral Medications: Wider but Uneven Coverage
Oral weight loss medications have been around longer, cost far less, and are covered by more state Medicaid programs. These include phentermine (one of the oldest prescription diet drugs), phentermine-topiramate (Qsymia), and naltrexone-bupropion (Contrave). Orlistat, which blocks fat absorption, is another option some states include.
Coverage criteria for these oral medications are generally less restrictive than for GLP-1s. A typical state Medicaid plan requires adults to have a BMI of 30 or higher, or a BMI of 27 or higher combined with at least one weight-related condition such as high blood pressure, diabetes, high cholesterol, or sleep apnea. For adolescents ages 12 to 17, the threshold is typically a BMI at or above the 95th percentile for their age and sex, or the 85th percentile with a qualifying health condition.
These medications produce more modest results than GLP-1s, with typical weight loss in the range of 5% to 10% of body weight. But their lower cost makes states more willing to cover them.
The Prior Authorization Process
Regardless of which medication you’re prescribed, expect to go through prior authorization. This means your doctor submits paperwork to Medicaid documenting that you meet specific clinical criteria before the pharmacy will fill your prescription. The process typically takes a few days to a couple of weeks.
Your doctor will need to document your current BMI, any weight-related health conditions, and in some states, that you’ve already tried lifestyle changes like diet and exercise programs. Some state programs require you to have tried and failed a preferred (usually cheaper) medication before approving a non-preferred one. For GLP-1 injectables specifically, your prescriber may need to attest that you meet the morbid obesity threshold and that other treatments have been insufficient.
If your initial request is denied, you have the right to appeal. Denials sometimes happen because of missing documentation rather than actual ineligibility, so working closely with your prescriber’s office to ensure complete paperwork matters.
Managed Care Adds Another Layer
Most Medicaid beneficiaries are enrolled in managed care plans rather than traditional fee-for-service Medicaid. These managed care organizations can set their own formularies (lists of covered drugs) within state guidelines, which means two people in the same state with different Medicaid managed care plans may have different medication options. Your specific plan’s formulary is the most reliable source for what’s actually available to you. You can usually find it on your plan’s website or by calling the member services number on your card.
Federal Policy Could Change the Picture
The Biden administration proposed a rule that would have required all state Medicaid programs to cover anti-obesity medications for people with obesity (not just those who are overweight). The Centers for Medicare and Medicaid Services estimated this would expand access to about 4 million Medicaid beneficiaries and increase Medicaid spending by roughly $15 billion over 10 years, split between the federal government ($11 billion) and states ($4 billion).
That proposal was never finalized before the change in administration, and its future remains uncertain. If a federal mandate does eventually take effect, it would represent the single biggest expansion of weight loss medication access for Medicaid enrollees, eliminating the state-by-state patchwork that currently exists. Until then, coverage remains optional for states, and cost pressures continue to push some states to drop coverage rather than add it.
How to Find Your State’s Coverage
The fastest way to determine what’s covered under your specific Medicaid plan is to check your plan’s preferred drug list, sometimes called a formulary. You can typically find this by searching your state’s Medicaid website or your managed care plan’s site for “pharmacy” or “formulary.” Calling your plan’s pharmacy benefits line with the specific drug name and your prescriber’s information will get you the most accurate, up-to-date answer, including any prior authorization requirements and step therapy rules you’ll need to satisfy.
If your state doesn’t cover the medication you want, ask your doctor about alternatives that are on your plan’s formulary. A covered medication that you can actually access and take consistently will produce better results than one you can’t afford or obtain.